Cargando…

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

BACKGROUNDS: Despite reported discordance between the mutational status of primary lung cancers and their metastases, metastatic sites are rarely biopsied and targeted therapy is guided by genetic biomarkers detected in the primary tumor. This situation is mostly explained by the apparent stability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quéré, Gilles, Descourt, Renaud, Robinet, Gilles, Autret, Sandrine, Raguenes, Odile, Fercot, Brigitte, Alemany, Pierre, Uguen, Arnaud, Férec, Claude, Quintin-Roué, Isabelle, Le Gac, Gérald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788951/ https://www.ncbi.nlm.nih.gov/pubmed/26968843 http://dx.doi.org/10.1186/s12885-016-2249-6

Ejemplares similares

Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography
por: Le Maréchal, Cedric, et al.
Publicado: (2001)

Henoch–Schönlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management
por: Philippe, Éloïse, et al.
Publicado: (2021)

Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases
por: Geier, Margaux, et al.
Publicado: (2021)

Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
por: Mercier, Anaïs, et al.
Publicado: (2023)

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)
por: Renaud, Emmanuelle, et al.
Publicado: (2023)

Real‐life second‐line epirubicin–paclitaxel regimen as treatment of relapsed small‐cell lung cancer: EpiTax study
por: Annic, Josselin, et al.
Publicado: (2022)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020)

Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
por: Saliou, Philippe, et al.
Publicado: (2013)

Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study
por: Scotet, Virginie, et al.
Publicado: (2018)

First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study
por: Amrane, Karim, et al.
Publicado: (2020)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Isolated metachronous splenic metastasis from synchronous colon cancer
por: Gencosmanoglu, Rasim, et al.
Publicado: (2006)

Multicentric Giant Cell Tumor of Bone: Synchronous and Metachronous Presentation
por: Wirbel, Reiner, et al.
Publicado: (2013)

HFE-Related Hemochromatosis: The Haptoglobin 2-2 Type Has a Significant but Limited Influence on Phenotypic Expression of the Predominant p.C282Y Homozygous Genotype
por: Le Gac, Gérald, et al.
Publicado: (2009)

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum
por: Nash, GF, et al.
Publicado: (2012)

Metachronous or synchronous male breast and prostate cancers a duality to lookout for.
por: Mukendi, Alain Mwamba, et al.
Publicado: (2019)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer
por: Shibukawa, Narihiro, et al.
Publicado: (2017)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
por: Menga, Alessio, et al.
Publicado: (2020)

Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation
por: Serio, Gabriella, et al.
Publicado: (2022)

Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors
por: Pan, Szu-Ying, et al.
Publicado: (2022)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

A Missense Mutation in the Alpha-Actinin 1 Gene (ACTN1) Is the Cause of Autosomal Dominant Macrothrombocytopenia in a Large French Family
por: Guéguen, Paul, et al.
Publicado: (2013)

Lung Cancer in an Orthoprosthetist Using Vermiculite
por: Durand-Moreau, Quentin, et al.
Publicado: (2017)

A rare case of metachronous neuroendocrine tumor after a colorectal adenocarcinoma: qualitative critical review of synchronous and metachronous gastrointestinal NET
por: Lancellotti, Francesco, et al.
Publicado: (2020)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection
por: Jang, Mi Young, et al.
Publicado: (2013)

Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
por: Lee, Janghee, et al.
Publicado: (2015)

Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
por: Suh, Byoung Jo
Publicado: (2016)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases
por: Sapalidis, Konstantinos, et al.
Publicado: (2018)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

An Unusual Occurrence of Multiple Metachronous and Synchronous Primary Cancers in a Female Patient
por: Torina, Tyler B., et al.
Publicado: (2020)

A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma
por: Pape, Marieke, et al.
Publicado: (2022)

Prognosis and histology of sporadic synchronous and metachronous meningiomas and comparative analyses with singular lesions
por: Kopf, Lisa, et al.
Publicado: (2023)

Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective
por: Guzzinati, Stefano, et al.
Publicado: (2023)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
por: Kim, Joo Hoon, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ontjb11en8976ldt9rjq1c9c0t